VEGFA and diabetic kidney disease: Consistent with this study, we previously observed the anti-inflammatory effects of exogenous VASH1 in association with the suppression of excessive VEGF-A signaling and the inhibition of the renal MCP-1 levels in experimental diabetic nephropathy [26].